Stable Cell Line

Stable Cell Line designates genetically engineered cell populations incorporating foreign DNA into chromosomes through stable integration, enabling consistent long-term expression of transgenes across cell divisions and passages without continuous selection pressure. These cell lines contrast with transient transfection providing temporary expression, with stable integration ensuring reproducible, sustained production essential for manufacturing or research requiring consistency.

The biopharmaceutical industry depends fundamentally on stable cell lines for producing recombinant proteins, monoclonal antibodies, and other biologics. Manufacturing cell line development involves transfecting expression vectors, applying selective pressure eliminating non-integrated cells, isolating clones through limiting dilution or flow cytometry, screening for high productivity, and characterising stability through extended culture. Chinese hamster ovary (CHO) cells dominate mammalian biomanufacturing, offering advantages including appropriate post-translational modifications, established regulatory precedent, and extensive engineering tools. Characterisation includes verifying transgene integration, measuring productivity, assessing genetic stability over passages, and banking validated cell lines. Master cell banks store extensively characterised clonal populations supporting manufacturing over the product lifetime. Advanced approaches employ targeted integration at defined genomic safe harbours improving consistency. As genome editing enables precise modifications and understanding grows regarding optimal integration sites, stable cell line generation continues advancing supporting efficient biomanufacturing.